Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Drilon

Showing results (261-270 of 269) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 269 results.
The New England Journal of Medicine|August 27, 2020
Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small-Cell Lung CancerAlexander Drilon, Geoffrey R Oxnard, Daniel S W Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET RegistryOliver Gautschi, Julie Milia, Thomas Filleron, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Cancer Cell|April 19, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Pageof 27

Showing results (261-270 of 269) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
The New England Journal of Medicine|August 27, 2020
Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small-Cell Lung CancerAlexander Drilon, Geoffrey R Oxnard, Daniel S W Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET RegistryOliver Gautschi, Julie Milia, Thomas Filleron, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Cancer Cell|April 19, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Pageof 27